Results 91 to 100 of about 6,727 (271)

Exploring Glaucoma: From Pathogenesis to Emerging Diagnostic and Management Strategies

open access: yesJournal of Ophthalmology, Volume 2025, Issue 1, 2025.
Glaucoma is a leading cause of irreversible blindness globally, affecting millions of individuals. It encompasses a group of progressive optic neuropathies characterized by retinal ganglion cell loss and visual field deterioration, often associated with elevated intraocular pressure.
Rajesh Kumar Goit, Nilufer Yesilirmak
wiley   +1 more source

Citicoline Improves Human Vigilance and Visual Working Memory: The Role of Neuronal Activation and Oxidative Stress

open access: yesBasic and Clinical Neuroscience, 2020
Introduction: Psychomotor performance task is used to assess the arousal and cognitive functions of the central nervous system. Alternatively, human visual working memory reflects the capability of the individual’s short-term memory.
Hayder M. Al-kuraishy, Ali I. Al-Gareeb
doaj  

Interventions for preventing delirium in hospitalised non-ICU patients [PDF]

open access: yes, 2016
BACKGROUND: Delirium is a common mental disorder, which is distressing and has serious adverse outcomes in hospitalised patients. Prevention of delirium is desirable from the perspective of patients and carers, and healthcare providers.
Clegg, Andrew   +6 more
core   +2 more sources

Polytreatment in a very old patient. What’s better for safe prescribing?

open access: yesAlzheimer's &Dementia, Volume 20, Issue S5, December 2024.
Abstract Background Prescription for inappropriate drugs can be dangerous to very old people, due to the increased risk of adverse drug reactions. Case report We report the consequences of inappropriate prescriptions in a 99‐year‐old woman. She had a clinical history of vascular dementia, diabetes, hypothyroidism, heart failure, osteoarthritis, chronic
Pietro Gareri   +3 more
wiley   +1 more source

Neuroprotezione del paziente con glaucoma cronico ad angolo aperto:ruolo della Citicolina in soluzione orale [PDF]

open access: yes, 2011
Aim: To verify the efficacy of Citicoline, taken orally, in the prevention of neurological damage in patients with Chronic Open Angle Glaucoma (COA G). Methods: 30 subjects with COA G were divided into 2 groups: 18 subjects (CT group) were treated with ...
Badalamenti, R.   +3 more
core  

Edaravone's Safety Profile in Acute Ischemic Stroke

open access: yesBrain and Behavior, Volume 14, Issue 12, December 2024.
 Participants: 64 enrolled, 58 completed edaravone treatment, 4 did not finish, 2 dropped out. Demographics: Majority male (n = 35), median age 53.5 years, 81.03% with moderate stroke severity. Findings: Two patients reported headaches, one reported dizziness; no serious adverse events documented.
Laurence K. J. Batino   +2 more
wiley   +1 more source

Изучение влияния комбинированного использования метилпреднизолона с цитиколином на процессы энергообеспечения митохондрий нейронов коры головного мозга и гистоморфометрические показатели его образований в условиях рассеянного склероза в эксперименте [PDF]

open access: yes, 2016
Study of combined use of methylprednisolone with citicoline to processes of energy providing of mitochondria to cortical neurons of the brain and histomorphometric indicators of its formation in the conditions of multiple sclerosis in the experiment ...
Мамчур, Виталий   +2 more
core  

Disorders of the immune status in patients with chronic cerebral ischemia; differentiated pharmacological correction [PDF]

open access: yes, 2018
The objective of the study is to establish the immune disorder patterns in patients with CCI I-II associated with arterial hypertension and to develop differentiated pharmacological methods for their ...
Bystrova, N. A.   +2 more
core   +2 more sources

Insights into Advances and Applications of Biomaterials for Nerve Tissue Injuries and Neurodegenerative Disorders

open access: yesMacromolecular Bioscience, Volume 24, Issue 12, December 2024.
This review addresses different types of biomaterials and their applications in treating nerve tissue injuries and neurodegenerative disorders. Moreover, it highlights several FDA‐approved biomaterial‐based products and ongoing clinical trials on biomaterials for nerve tissue regeneration.
Varsha Pai   +2 more
wiley   +1 more source

EFEK PEMBERIAN CITICOLINE TERHADAP STATUSRNFUNGSIONAL PASCACEDERA SARAF SCIATICUSRNPADA TIKUS PUTIH (RATTUS NORVEGICUS) [PDF]

open access: yes, 2015
Citicoline (CDP-choline) is an endogenous compound that serves as anintermediate compound in the synthesis of membrane phospholipids, acetylcholinesynthesis and as a metal donor. Citicoline can provide cholinergic andneuroprotective effects.
FAJRIAH
core  

Home - About - Disclaimer - Privacy